Liver Cancer
Transgastric fine-needle biopsies sample high risk patients for malignancy
Published in Hepatitis Weekly, January 5th, 2004
"Hepatocellular carcinoma (HCC) is the most common primary malignancy arising within the liver and most often affects individuals with chronic hepatitis and/or liver cirrhosis. Patients often present at an advanced stage of disease or with poor liver function, thus limiting treatment options and resulting in a poor prognosis of the disease. Therefore, an early tissue-based diagnosis of HCC is necessary to direct further work-up and treatment," scientists writing in the journal Zeitschrift Fur Gastroenterologie report.
"We present the case of a 70-year-old man with...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2004-01-05)
More Articles from Hepatitis Weekly
- Ischemia
Shock is an underlying factor in hypoxic hepatitis only half of the time - Cancer Prevention
Organosulfer compounds stop liver cancer invasion, migration, and angiogenesis - Chronic Hepatitis C
Impaired interleukin-15 production impedes the effectiveness of interferon - Dermatology
The antifungal ketoconazole may cause liver injury - Diagnostics
The Chemagic viral DNA/RNA kit improves viral extraction - Echinococcosis
Advanced and refractory human alveolar echinococcosis responds to amphotericin B - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
